Autres langues IMV Corporation

Actions

7760

JP3100760002

Marché Fermé - Japan Exchange Autres places de cotation 08:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
638 ^JPY	-0,31 %		+1,92 %	+22,46 %

25/03	BioVaxys Technology prévoit un placement privé ; baisse de 5,9	MT
2023	IMV Corporation (TSE:7760) annonce un rachat d'actions pour 400.000 actions, représentant 2,45% pour 250 millions ¥.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.	09/04
BioVaxys Technology Plans Private Placement; Down 5.9%	25/03
Biovaxys Completes The Acquisition Of All Intellectual Property And Clinical Stage Assets Of The Former IMV Inc.	21/02
BioVaxys Acquires Entire Technology Portfolio Of The Former IMV Inc.	12/02
Tranche Update on IMV Corporation's Equity Buyback Plan announced on November 21, 2023.	15/01
IMV Corporation announces an Equity Buyback for 400,000 shares, representing 2.45% for ¥250 million.	21/11
IMV Corporation authorizes a Buyback Plan.	21/11
IMV Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	10/11
EKF Diagnostics hires CFO from Trellus Health, latter names successor	12/09/23
Trellus Health's Interim Finance Head Takes Full-time CFO Role at EKF Diagnostics	12/09/23
Imv Corporation Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023	09/06/23
Imv Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023	09/06/23
IMV Corporation Reports Earnings Results for the Half Year Ended March 31, 2023	12/05/23
IMV Receives Delisting Notice From Nasdaq Over Bankruptcy Proceedings in Canada	09/05/23
IMV Inc. Brief: Says Received NASDAQ Delisting Notice	08/05/23
IMV Inc. Brief: Says Received Nasdaq Notification Regarding Minimum Bid Price Deficiency	31/03/23
IMV Inc. Details Board Changes	27/03/23
IMV Inc. Brief: Hall Adds Co engaged Stonegate to explore strategic alternatives, "So that MVP-S can realize its full clinical potential"	16/03/23
IMV Inc. Brief: Andrew Hall, Chief Executive Officer, Said" "The market headwinds limiting available capital are, however, very real"	16/03/23
IMV Inc. Brief: Net loss and comprehensive loss of US$38.0 million ($4.55 per share) for Year ended December 31, 2022, Vs net loss and comprehensive loss of $36.6 ($4.93 per share) for Year ended December 31, 2021	16/03/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues IMV Corporation

Actions

7760

JP3100760002

Autres langues

Filtres